Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3277914
Max Phase: Preclinical
Molecular Formula: C41H64N12O12S2
Molecular Weight: 981.17
Molecule Type: Protein
Associated Items:
ID: ALA3277914
Max Phase: Preclinical
Molecular Formula: C41H64N12O12S2
Molecular Weight: 981.17
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C41H64N12O12S2/c1-6-20(4)33-41(65)48-25(11-12-30(43)55)37(61)51-28(15-31(44)56)38(62)52-29(40(64)47-21(5)34(58)49-26(13-19(2)3)36(60)46-16-32(45)57)18-67-66-17-24(42)35(59)50-27(39(63)53-33)14-22-7-9-23(54)10-8-22/h7-10,19-21,24-29,33,54H,6,11-18,42H2,1-5H3,(H2,43,55)(H2,44,56)(H2,45,57)(H,46,60)(H,47,64)(H,48,65)(H,49,58)(H,50,59)(H,51,61)(H,52,62)(H,53,63)/t20-,21-,24-,25-,26-,27-,28-,29-,33-/m0/s1
Standard InChI Key: KTBYUIUIXKJTJF-ONRYPPOPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 981.17 | Molecular Weight (Monoisotopic): 980.4208 | AlogP: -4.09 | #Rotatable Bonds: 18 |
Polar Surface Area: 408.32 | Molecular Species: BASE | HBA: 15 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.51 | CX Basic pKa: 19.84 | CX LogP: -5.27 | CX LogD: -5.58 |
Aromatic Rings: 1 | Heavy Atoms: 67 | QED Weighted: 0.06 | Np Likeness Score: 0.53 |
1. Walter R, Smith CW, Roy J, Formento A.. (1976) Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones., 19 (6): [PMID:985884] [10.1021/jm00228a017] |
Source(1):